Quaternary Prevention, an Answer of Family Doctors to Overmedicalization

Document Type: Perspective

Author

Espace Temps, Maison de Santé, Charleroi, Belgium, and Department of General Practice, University of Liege, Liège, Belgium

Abstract

In response to the questioning of Health Policy and Management (HPAM) by colleagues on the role of rank and file family physicians in the same journal, the author, a family physician in Belgium, is trying to highlight the complexity and depth of the work of his colleagues and their contribution to the understanding of the organization and economy of healthcare. It addresses, in particular, the management of health elements throughout the ongoing relationship of the family doctor with his/her patients. It shows how the three dimensions of prevention, clearly included in the daily work, are complemented with the fourth dimension, quaternary prevention or prevention of medicine itself, whose understanding could help to control the economic and human costs of healthcare.

Highlights

Commentaries Published on this Paper

  • Quaternary Prevention and the Challenges to Develop a Good Practice; Comment on “Quaternary Prevention, an Answer of Family Doctors to Overmedicalization”

            Abstract | PDF

  • Care and Do Not Harm: Possible Misunderstandings With Quaternary Prevention (P4); Comment on “Quaternary Prevention, an Answer of Family Doctors to Over Medicalization”

            Abstract | PDF

  • The Difficult Choice of “Not Doing”; Comment on “Quaternary Prevention, an Answer of Family Doctors to Overmedicalization”

            Abstract | PDF

  • Because of Science You Also Die...; Comment on “Quaternary Prevention, an Answer of Family Doctors to Over Medicalization”

            Abstract | PDF

Keywords

Main Subjects


  1. Chinitz DP, Rodwin VG. On Health Policy and Management (HPAM): mind the theory-policy-practice gap. Int J Health Policy Manag 2014; 3: 3613. doi: 10.15171/ijhpm.2014.122
  2. Harrison C, Britt H, Miller G, Henderson J. Prevalence of chronic conditions in Australia. PLoS One  2013; 8: e67494. doi: 10.1371/journal.pone.0067494
  3. Gijsen R, Poos R. Using registries in general practice to estimate countrywide morbidity in the Netherlands. Public Health 2006; 120: 923-36. doi: 10.1016/j.puhe.2006.06.005
  4. Lykkegaard J, Larsen PV, Paulsen MS, Søndergaard J. General practitioners’ home visit tendency and readmission-free survival after COPD hospitalisation: a Danish nationwide cohort study. NPJ Prim care Respir Med 2014; 24: 14100. doi: 10.1038/npjpcrm.2014.100
  5. Laux G, Kuehlein T, Rosemann T, Szecsenyi J. Co- and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project. BMC Health Serv Res 2008; 8: 14. doi: 10.1186/1472-6963-8-14
  6. Lamberts H, Meads S, Wood M. Classification of reasons why persons seek primary care: pilot study of a new system. Public Heal Rep 1984; 99: 597-605.
  7. Soler JK, Okkes I, Wood M, Lamberts H. The coming of age of ICPC: celebrating the 21st birthday of the International Classification of Primary Care. Fam Pract. 2008; 25: 312-7. doi: 10.1093/fampra/cmn028
  8. Leavell H, Clark E. Preventive Medicine for the Doctor in His Community an Epidemiologic Approach. McGraw-Hill; 1958. 
  9. Jamoulle M. Information et informatisation en médecine générale [Computer and computerisation in general practice]. Dans: Les informa-g-iciens. Namur, Belgium: Press Univ Namur; 1986. p. 193–209. Available from: http://hdl.handle.net/2268/170822
  10. Jamoulle M, Roland M. Quaternary prevention. WICC annual workshop: Hongkong, Wonca congress proceedings; 1995.  Available from:  http://hdl.handle.net/2268/173994
  11. Jamoulle M. The four duties of family doctors: quaternary prevention - first, do no harm. Hong Kong Pract 2014; 36: 72-7.
  12. Bentzen N. Wonca Dictionary of General/Family Practice. Maanedsskr: Copenhagen; 2003. 
  13. Norman AH, Tesser CD. [Quaternary prevention in primary care: a necessity for the Brazilian Unified National Health System]. Cad Saude Publica 2009; 25: 2012-20.  doi: 10.1590/S0102-311X2009000900015
  14. De Vito EL. Prevención cuaternaria, un término aún no incluido entre los MESH. Med (Buenos Aires). Fundación Revista Medicina (Buenos Aires) 2013; 73: 187-90.
  15. Silva AL, Mangin D, Pizzanelli M, Jamoulle M, Wagner HL, Silva DH, et al. Manifesto de Curitiba: pela Prevenção Quaternária e por uma Medicina sem conflitos de interesse. Rev Bras Med Família e Comunidade 2014; 9: 371–4.  [in Portuguese]
  16. Kuehlein T, Sghedoni D, Visentin G, Gérvas J, Jamoulle M. Quaternary prevention: a task of the general practitioner. Prim Care [Internet]. 2010. Available from: http://www.primary-care.ch/docs/primarycare/archiv/de/2010/                                   2010-18/2010-18-368_ELPS_engl.pdf
  17. Jamoulle M, Tsoi G, Heath I, Mangin D, Pezeshki M, Pizzanelli Báez M.  Quaternary prevention,   addressing the limits of medical practice. Wonca world conference Prague; 2013.  Available from:  http://www.ph3c.org/PH3C/docs/27/000322/0000469.pdf
  18. Martin C, Heleno B, Hestbech M, Brodersen J. Screening Evidence And Wishful Thinking – A Europrev Workshop About Quaternary Prevention In General Practice. WONCA Europe Conference 2014, Lisbon, Portugal; 2014. Available from:     http://www.woncaeurope.org/content/ws407-screening-evidence-and-wishful-thinking-%E2%80%93-europrev-workshop-about-quaternary
  19. Jamoulle M, Roland M.  Quaternary prevention. From Wonca world Hong Kong 1995 to Wonca world Prague 2013. In Wonca world conference Prague 2013 [Poster]. Available also in Chinese, Thai, Vietnamese, French, Spanish and Portuguese on www.ph3c.org/P4
  20. Tsoi G. Quaternary prevention. Hong Kong Pract 2014; 36: 49-50.
  21. Alonso-Coello P, García-Franco AL, Guyatt G, Moynihan R. Drugs for pre-osteoporosis: prevention or disease mongering? BMJ 2008; 336: 126 -9. doi: 10.1136/bmj.39435.656250.AD
  22. Conrad P, Bergey MR. The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder. Soc Sci Med 2014; 122: 31-43. doi: 10.1016/j.socscimed.2014.10.019
  23. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002; 324: 886-91. doi: 10.1136/bmj.324.7342.886
  24. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane database Syst Rev 2009; 4: CD001877. doi: 10.1002/14651858.CD001877.pub3
  25. Tomljenovic L, Shaw CA. Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Ann Med 2013; 45: 182-93. doi: 10.3109/07853890.2011.645353
  26. Wolinsky H. Disease mongering and drug marketing. Does the pharmaceutical industry manufacture diseases as well as drugs? EMBO Rep 2005; 6P: 612–4. doi: 10.1038/sj.embor.7400476
  27. Mariño Maria A. Incidentaloma. Rev Bras Med Família e Comunidade 2015; forthcoming.
  28. Welch HG. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston, MA : Beacon Press; 2012.
  29. Heath I. Combating Disease Mongering: Daunting but Nonetheless Essential. PLoS Med 2006; 3: e146. doi: 10.1371/journal.pmed.0030146
  30. Kuehlein T, Sghedoni D, Visentin G, Gérvas J, Jamoulle M. Quaternary prevention: a task of the general practitioner. Prim Care [internet]. 2010. Available from: http://www.primary-care.ch/pdf_f/2010/2010-18/2010-18-368_ELPS_engl.pdf
  31. Light DW, Lexchin J, Darrow JJ. Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs. J Law Med Ethics 2013; 14: 590-600.
  32. Rodwin MA. Institutional Corruption & Pharmaceutical Policy. J Law Med Ethics 2013; 41: 544-52.
  33. Gotzsche PG. Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare. London: Radcliffe Publishing Ltd; 2013. 
  34. Mangin D, Heath I, Jamoulle M. Beyond diagnosis: rising to the multimorbidity challenge. Br Med J 2012; 344: e3526. doi: 10.1136/bmj.e3526
  35. Giguere A, Labrecque M, Haynes R, Grad R, Pluye P, Légaré F, et al. Evidence summaries (decision boxes) to prepare clinicians for shared decision-making with patients: a mixed methods implementation study. Implement Sci 2014; 9: 144. doi: 10.1186/s13012-014-0144-6
  36. Feldman AM. Understanding Health Care Reform: Bridging the Gap Between Myth and Reality. New York, NY: CRC Press; 2011.
  37. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000; 321: 355-8.
  38. Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med  2014; 174: 448–54. doi: 10.1001/jamainternmed.2013.13635
  39. Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential Overtreatment of Diabetes Mellitus in Older Adults With Tight Glycemic Control. JAMA Intern Med 2015.  doi: 10.1001/jamainternmed.2014.7345   
  40. Al-Nabhani K, Kakaria A, Syed R. Computed tomography in management of patients with non-localizing headache. Oman Med J 2014; 29: 28-31. doi: 10.5001/omj.2014.07
  41. Légaré F, Ratté S, Stacey D, Kryworuchko J, Gravel K, Graham ID, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane database Syst Rev 2010; (5): CD006732. doi: 10.1002/14651858.CD006732.pub2
  42. Widmer D, Herzig L, Jamoulle M. [Quaternary prevention: is acting always justified in family medicine?]. Rev Med Suisse 2014; 10: 1052-6. [in French]
  43. Heath I. The art of doing nothing. Eur J Gen Pract 2012; 18: 242-6. doi: 10.3109/13814788.2012.733691
  44. Báez EM. Princípios Éticos e Prevenção Quaternária: é possível não proteger o exercício do princípio da autonomia? [Ethical Principles and Quaternary Prevention: is it possible not to protect the exercise of the principle of autonomy?] Rev Bras Med Família e Comunidade 2013; 9: 169-73. [in Portuguese]
  45. Sharpe VA. Why “Do No Harm”? The Influence of Edmund D. Pellegrino’s Philosophy of Medicine. Theor Med 1997; 18: 197-215. doi: 10.1007/978-94-017-3364-9